glp 1 agonist structure Crystal of the GLP-1 receptor bound to a peptide Crystal structure of the GLP-1
Description
The recently initiated large-sized FLOW trial investigating the effects of semaglutide on hard renal outcomes in patients with DKD will provide clarity whether GLP-1 receptor agonists may reduce the burden of DKD in addition to their other beneficial metabolic and cardiovascular effects.
Delve into the perspectives of employers and health plans on obesity, GLP-1 coverage rates, and concerns about off-label use.
Background Glucagon-like peptide-1 (GLP-1) induces diuresis and natriuresis
However, few research has explored its role o...
A new case report highlights the potential risk of "anhedonia" from high doses of tirzepatide, though it can be treated effectively.
